Clinical Trials Logo

Clinical Trial Summary

The primary purpose of the study is to identify the factors of steroid dependency in childhood idiopathic nephrotic syndrome. The steroid dependency is defined by a relapse of nephrotic syndrome within the 3 weeks that follow the withdrawal of steroid therapy after the first manifestation. Different clinical and biological factors will be analyzed: age of first manifestation, delay of remission, ethnicity, and preceding viral infection, geolocalization in the Parisian area, genoprevalence of herpes viruses and polymorphisms in the genes involved in the response to steroid therapy.


Clinical Trial Description

Patients with a steroid dependent nephrotic syndrome will be compared to those with a non steroid dependent form of nephrotic syndrome at the end of the first manifestation. An additional blood volume will be sampled in patients and controls during a scheduled biological check-up for the initial disease. Genetics factors will be checked using a DNA chips devoted to the response to steroid therapy and viral genome of EBV, CMV, HHV7 will be searched for using PCR reaction in total blood DNA extract. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01609426
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date June 2016

See also
  Status Clinical Trial Phase
Completed NCT01092962 - Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children Phase 3
Recruiting NCT04075656 - UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort) N/A
Recruiting NCT02896270 - Valproic Acid for Idiopathic Nephrotic Syndrome Phase 2/Phase 3
Completed NCT04034316 - Reduce Immunosuppression With Atmp in NS ChildrEn Phase 2
Completed NCT00255398 - Kidney Disease Biomarkers
Recruiting NCT04207580 - A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
Completed NCT04494438 - Rituximab for Idiopathic Nephrotic Syndrome Phase 3
Active, not recruiting NCT01346007 - Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome Phase 4
Completed NCT04169776 - Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome N/A
Recruiting NCT03298698 - Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Phase 3
Recruiting NCT03949972 - The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)